PTC Therapeutics Inc (PTCT) — Cash Flow Reinvestment Rate
PTC Therapeutics Inc (PTCT) has a Cash Flow Reinvestment Rate of 0.21x as of March 2025, reinvesting $186.89 Million (capex $2.53 Million plus investments $-184.36 Million) from operating cash flow of $870.10 Million. Check PTC Therapeutics Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
PTC Therapeutics Inc Cash Flow Reinvestment Rate (2025–2025)
Historical reinvestment intensity for PTC Therapeutics Inc across 1 annual periods. Explore PTC Therapeutics Inc (PTCT) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for PTC Therapeutics Inc (2025–2025)
Year-by-year capital reinvestment analysis for PTC Therapeutics Inc. For live market cap and broader valuation context, see PTCT stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.80x | $570.90 Million | $711.20 Million | $8.86 Million | — |